Cargando…

The α-Synuclein Origin and Connectome Model (SOC Model) of Parkinson’s Disease: Explaining Motor Asymmetry, Non-Motor Phenotypes, and Cognitive Decline

A new model of Parkinson’s disease (PD) pathogenesis is proposed, the α-Synuclein Origin site and Connectome (SOC) model, incorporating two aspects of α-synuclein pathobiology that impact the disease course for each patient: the anatomical location of the initial α-synuclein inclusion, and α-synucle...

Descripción completa

Detalles Bibliográficos
Autor principal:	Borghammer, Per
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150555/ https://www.ncbi.nlm.nih.gov/pubmed/33682732 http://dx.doi.org/10.3233/JPD-202481

Ejemplares similares

The Clinical Non-Motor Connectome in Early Parkinson’s Disease
por: Diederich, Nico J., et al.
Publicado: (2020)

Antagonistic network signature of motor function in Parkinson’s disease revealed by connectome-based predictive modeling
por: Wang, Xuyang, et al.
Publicado: (2022)

Alpha-Synuclein and Parkinson’s Disease Motor and Non-Motor Symptoms: What Is New?
por: Grigoletto, Jessica, et al.
Publicado: (2022)

Lesioning of the Striatum Reverses Motor Asymmetry in the 6-Hydroxydopamine Rodent Model of Parkinsonism
por: Friehs, G. M., et al.
Publicado: (1991)

Nicotine-Mediated Recruitment of GABAergic Neurons to a Dopaminergic Phenotype Attenuates Motor Deficits in an Alpha-Synuclein Parkinson’s Model
por: Lai, Jessica IChi, et al.
Publicado: (2023)

MLKL deficiency alleviates neuroinflammation and motor deficits in the α-synuclein transgenic mouse model of Parkinson’s disease
por: Geng, Lu, et al.
Publicado: (2023)

Motor Asymmetry and Interocular Retinal Thickness in Parkinson's Disease
por: Baek, Sung Uk, et al.
Publicado: (2021)

Identifying a whole‐brain connectome‐based model in drug‐naïve Parkinson's disease for predicting motor impairment
por: Wu, Haoting, et al.
Publicado: (2021)

Passive Immunization in Alpha-Synuclein Preclinical Animal Models
por: Folke, Jonas, et al.
Publicado: (2022)

Impaired aldehyde detoxification exacerbates motor deficits in an alpha‐synuclein mouse model of Parkinson's disease
por: Martinez, Paul Anthony, et al.
Publicado: (2023)

Preclinical reserpine models recapitulating motor and non-motor features of Parkinson’s disease: Roles of epigenetic upregulation of alpha-synuclein and autophagy impairment
por: Li, Yang, et al.
Publicado: (2022)

Harmol promotes α-synuclein degradation and improves motor impairment in Parkinson’s models via regulating autophagy-lysosome pathway
por: Xu, Jie, et al.
Publicado: (2022)

Optimized connectome architecture for sensory-motor integration
por: Worrell, Jacob C., et al.
Publicado: (2017)

Anle138b modulates α‐synuclein oligomerization and prevents motor decline and neurodegeneration in a mouse model of multiple system atrophy
por: Heras‐Garvin, Antonio, et al.
Publicado: (2018)

Motor symptom asymmetry predicts non-motor outcome and quality of life following STN DBS in Parkinson's disease
por: Voruz, Philippe, et al.
Publicado: (2022)

Does Motor Symptoms Asymmetry Predict Motor Outcome of Subthalamic Deep Brain Stimulation in Parkinson's Disease Patients?
por: Bove, Francesco, et al.
Publicado: (2022)

α-Synuclein Genetic Variants Predict Faster Motor Symptom Progression in Idiopathic Parkinson Disease
por: Ritz, Beate, et al.
Publicado: (2012)

The role of APOE in cognitive trajectories and motor decline in Parkinson’s disease
por: Jo, Sungyang, et al.
Publicado: (2021)

Neurofilament light as a biomarker for motor decline in Parkinson’s disease
por: Liu, Yumei, et al.
Publicado: (2022)

Neurophysiological brain-fingerprints of motor and cognitive decline in Parkinson’s disease
por: da Silva Castanheira, Jason, et al.
Publicado: (2023)

Alpha-Synuclein and Cognitive Decline in Parkinson Disease
por: Fan, Tian-Sin, et al.
Publicado: (2021)

Plasma α-synuclein predicts cognitive decline in Parkinson’s disease
por: Lin, Chin-Hsien, et al.
Publicado: (2017)

Impaired Structural Motor Connectome in Amyotrophic Lateral Sclerosis
por: Verstraete, Esther, et al.
Publicado: (2011)

Running wheel exercise reduces α-synuclein aggregation and improves motor and cognitive function in a transgenic mouse model of Parkinson's disease
por: Zhou, Wenbo, et al.
Publicado: (2017)

Proteasome-targeted nanobodies alleviate pathology and functional decline in an α-synuclein-based Parkinson’s disease model
por: Chatterjee, Diptaman, et al.
Publicado: (2018)

Pre-Fibrillar α-Synuclein Mutants Cause Parkinson's Disease-Like Non-Motor Symptoms in Drosophila
por: Gajula Balija, Madhu Babu, et al.
Publicado: (2011)

Motor and Nonmotor Symptoms of Parkinson's Disease: Antagonistic Pleiotropy Phenomena Derived from α-Synuclein Evolvability?
por: Takamatsu, Yoshiki, et al.
Publicado: (2018)

Cognitive decline tracks motor progression and not disease duration in Parkinson patients
por: Riggeal, BD, et al.
Publicado: (2007)

Charting the onset of Parkinson-like motor and non-motor symptoms in nonhuman primate model of Parkinson’s disease
por: Choudhury, Gourav R., et al.
Publicado: (2018)

Prediction of Deep Brain Stimulation Outcome in Parkinson’s Disease With Connectome Based on Hemispheric Asymmetry
por: Wang, Jingqi, et al.
Publicado: (2021)

Parkin depletion delays motor decline dose-dependently without overtly affecting neuropathology in α-synuclein transgenic mice
por: Fournier, Margot, et al.
Publicado: (2013)

Neuronal connectome of a sensory-motor circuit for visual navigation
por: Randel, Nadine, et al.
Publicado: (2014)

Models of α-synuclein aggregation in Parkinson’s disease
por: Giráldez-Pérez, Rosa María, et al.
Publicado: (2014)

Imbalanced motivated behaviors according to motor sign asymmetry in drug-naïve Parkinson’s disease
por: Béreau, Matthieu, et al.
Publicado: (2023)

ATP13A2 Declines Zinc-Induced Accumulation of α-Synuclein in a Parkinson’s Disease Model
por: Gao, Huiling, et al.
Publicado: (2022)

Plasma pS129-α-Synuclein Is a Surrogate Biofluid Marker of Motor Severity and Progression in Parkinson’s Disease
por: Lin, Chin-Hsien, et al.
Publicado: (2019)

The Impact of SNCA Variations and Its Product Alpha-Synuclein on Non-Motor Features of Parkinson’s Disease
por: Magistrelli, Luca, et al.
Publicado: (2021)

Inhibiting α-Synuclein Oligomerization by Stable Cell-Penetrating β-Synuclein Fragments Recovers Phenotype of Parkinson's Disease Model Flies
por: Shaltiel-Karyo, Ronit, et al.
Publicado: (2010)

Association of GBA genotype with motor and cognitive decline in Chinese Parkinson’s disease patients
por: Ren, Jingru, et al.
Publicado: (2023)

Increased telomerase improves motor function and alpha-synuclein pathology in a transgenic mouse model of Parkinson’s disease associated with enhanced autophagy
por: Wan, Tengfei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mfp4dsv6815mm2p8vocd453kk0